Evidence map›Paper›PMID 33870056›Full record

ArticleFrontiers in research metrics and analytics2020

Tracking and Mining the COVID-19 Research Literature.

Alan L Porter, Yi Zhang, Ying Huang, Mengjia Wu

Abstract read
In one paragraph

Article in Frontiers in research metrics and analytics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The long COVID research literature.Frontiers in research metrics and analytics · 2023
    Pooled it
  2. Article
  3. Tech mining: a revisit and navigation.Frontiers in research metrics and analytics · 2024
    Review
  4. Responsible models and indicators: challenges from artificial intelligence.Frontiers in research metrics and analytics · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alan L PorterSearch Technology, Inc., Norcross, GA, United States.
Yi ZhangFaculty of Engineering and Information Technology, Australian Artificial Intelligence Institute, University of Technology Sydney, Ultimo, NSW, Australia.
Ying HuangDepartment of Management, Strategy and Innovation (MSI), Center for R&D Monitoring (ECOOM), KU Leuven, Leuven, Belgium.
Mengjia WuFaculty of Engineering and Information Technology, Australian Artificial Intelligence Institute, University of Technology Sydney, Ultimo, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The unprecedented, explosive growth of the COVID-19 domain presents challenges to researchers to keep up with research knowledge within the domain. This article profiles this research to help make that knowledge more accessible via overviews and novel categorizations. We provide websites offering means for researchers to probe more deeply to address specific questions. We further probe and reassemble COVID-19 topical content to address research issues concerning topical evolution and emphases on tactical vs. strategic approaches to mitigate this pandemic and reduce future viral threats. Data suggest that heightened attention to strategic, immunological factors is warranted. Connecting with and transferring in research knowledge from outside the COVID-19 domain demand a viable COVID-19 knowledge model. This study provides complementary topical categorizations to facilitate such modeling to inform future Literature-Based Discovery endeavors.

Indexed as

bibliometricscoronavirusCOVID-19pandemictech miningtext analysis

Identifiers

PMID33870056
PMCPMC8025982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.